Financings in Brief: Heartport
This article was originally published in The Gray Sheet
Executive Summary
Heartport: Chief financial officer Randall Livingston tells investors at the Robertson, Stephens medical conference that his firm is planning an initial public offering for the first half of 1996. The offering, contingent on continuing good market conditions, will follow completion of Phase I trials of Heartport's port-access system for coronary artery bypass grafting (CABG) and initiation of trials evaluating its port-access system for mitral valve replacement, Livingston said. Heartport unveiled its minimally invasive system for CABG in August, and entered an agreement in September with valve manufacturer St. Jude Medical to develop a system for valve replacement ("The Gray Sheet" Sept. 18, p. 22)...